Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. [PDF]
Bartalena L +4 more
core +1 more source
Classic autoimmune type 1 diabetes mellitus after a case of drug reaction with eosinophilia and systemic symptoms (DRESS). [PDF]
Chapman, Lance W +5 more
core +1 more source
Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves' Hyperthyroidism: The RISG Study. [PDF]
Karmisholt J +5 more
europepmc +1 more source
Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves' Disease. [PDF]
Liu J, Fu J, Duan Y, Wang G.
europepmc +1 more source
Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves' disease. [PDF]
Yasuda K +7 more
europepmc +1 more source
Predicting relapse of Graves' disease following treatment with antithyroid drugs. [PDF]
Liu L, Lu H, Liu Y, Liu C, Xun C.
europepmc +1 more source
HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. [PDF]
Kasamatsu D +4 more
europepmc +1 more source
Infection-Associated Transient Neutropenia Mimicking Methimazole-Induced Agranulocytosis in Graves' Disease: A Diagnostic Dilemma. [PDF]
Saiprasad S +3 more
europepmc +1 more source
Iodide for the management of Graves' disease in pregnancy. [PDF]
Yoshihara A, Noh JY, Watanabe N, Ito K.
europepmc +1 more source

